Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 8662 (116th)

Accelerating Access to Critical Therapies for ALS Act

referredUnited States· United States Congress· EN

Introduced

23 October 2020

Last action

23 October 2020 · Introduced

Status

Referred to the House Committee on Energy and Commerce.

Sponsors

Rep. Fortenberry, Jeff [R-NE-1], Rep. Quigley, Mike [D-IL-5], Rep. King, Peter T. [R-NY-2], Rep. Diaz-Balart, Mario [R-FL-26], Rep. Hern, Kevin [R-OK-1], Rep. Katko, John [R-NY-24], Rep. Gianforte, Greg [R-MT-At Large], Jim Hagedorn, Rep. Bacon, Don [R-NE-2], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Westerman, Bruce [R-AR-4], Rep. Smith, Adrian [R-NE-3], Rep. Biggs, Andy [R-AZ-5], Rep. McKinley, David B. [R-WV-1], Rep. Schweikert, David [R-AZ-1], Rep. Upton, Fred [R-MI-6], Rep. Rutherford, John H. [R-FL-5], Sen. Mullin, Markwayne [R-OK], Rep. King, Steve [R-IA-4], Rep. Amodei, Mark E. [R-NV-2], Sen. Marshall, Roger [R-KS], Rep. Stivers, Steve [R-OH-15], Rep. Timmons, William R. [R-SC-4], Rep. Velázquez, Nydia M. [D-NY-7], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Costa, Jim [D-CA-21], Rep. Rush, Bobby L. [D-IL-1], Rep. Rouda, Harley [D-CA-48], Rep. Sewell, Terri A. [D-AL-7], Rep. Beatty, Joyce [D-OH-3], Rep. O'Halleran, Tom [D-AZ-1], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. Lowenthal, Alan S. [D-CA-47], David Scott, Rep. Calvert, Ken [R-CA-41], Sen. Welch, Peter [D-VT], Rep. Peterson, Collin C. [D-MN-7], Rep. Demings, Val Butler [D-FL-10], Rep. Schakowsky, Janice D. [D-IL-9], Sen. Schiff, Adam B. [D-CA], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Pressley, Ayanna [D-MA-7], Rep. Joyce, David P. [R-OH-14], Sen. Blunt Rochester, Lisa [D-DE], Rep. Trahan, Lori [D-MA-3], Rep. Porter, Katie [D-CA-47], Rep. Golden, Jared F. [D-ME-2]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to support research on and facilitate access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases. HHS shall also establish the Collaborative for Neurodegenerative Diseases, which shall support the development and regulatory approval of drugs that address ALS and other rare neurodegenerative diseases.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 23 October 2020

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 23 October 2020

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 23 October 2020

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 23 October 2020

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 23 October 2020

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 23 October 2020

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 280 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.